Altimmune, Inc. (ALT)

4.225 -0.02 (-0.35%) USD  |  NASDAQ  |  Jan 20, 16:00
More

Altimmune Net Total Long Term Debt (Quarterly)

Net Total Long Term Debt (Quarterly) Chart

View Net Total Long Term Debt (Quarterly) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Total Long Term Debt (Quarterly) Range, Past 5 Years

View Net Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Total Long Term Debt (Quarterly) Benchmarks

View Net Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Seres Therapeutics, Inc. Upgrade